Skip to main content
Log in

Determination of protein binding byin vitro charcoal adsorption

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Certain compounds such as SC-52151 have extensive nonspecific adsorption to the ultrafiltration devices or to dialysis membranes and therefore can not be measured by the conventional ultrafiltration or equilibrium dialysis methods. A new method based on charcoal adsorption was developed to overcome this difficulty. Unlike many conventional methods, which are based on the separation of free drug from bound drug under equilibrium conditions, the new method is operated under nonequilibrium conditions and involves measuring the time course of decline of the percentage of bound drug remaining in plasma while the free drug is being removed by charcoal adsorption. Theoretical aspects of the method and the data processing procedure are presented. SC-98A, a compound with minimal nonspecific adsorption to the ultrafiltration membrane, was used to demonstrate the applicability of this method against the ultrafiltration method. Using this method, the protein binding of SC-52151 in human plasma at 1.0 μg/ml was determined to be in the range of 91.4–97.7% at room temperature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. L. Shargel and A. B. C. Yu.Applied Biopharmaceutics and Pharmacokinetics, 2nd ed., Appleton-Century-Crofts, Norwalk, CT, 1985, pp. 197–211.

    Google Scholar 

  2. J. B. Whitlan and K. F. Brown. Ultrafiltration in serum protein binding determinations.J. Pharm. Sci. 70:146–150 (1981).

    Article  Google Scholar 

  3. J. Kurz, J. Trunk, and B. Weitz. Evaluation of methods to determine protein-binding of drugs, equilibrium dialysis, ultrafiltration, ultracentrifugation, and gel filtration.Drug Res. 27:1373–1380 (1977).

    CAS  Google Scholar 

  4. G. W. Moll and R. L. Rosenfeld. Some limitations of using equilibrium dialysis to study human serum albumin-testosterone interaction.J. Clin. Endocrinal. Metab. 46:501–503 (1978).

    Article  CAS  Google Scholar 

  5. P. A. Bombardt, J. E. Brewer, and M. G. Johnson. Protein binding of Tirilazad (U-74006) in human, Sprague-Dawley rat, Beagle dog and cynomolgus monkey serum.J. Pharmacol. Exp. Ther. 269:145–150 (1994).

    CAS  PubMed  Google Scholar 

  6. D. P. Getman, G. A. DeCrescenzo, R. M. Heintz, K. L. Reed, J. J. Talley, M. L. Bryant, M. Clare, K. A. Houseman, J. J. Marr, R. A. Mueller, et al.. Discovery of a novel class of potent HIV-1 protease inhibitors containing the(R)-(hydroxyethyl)urea isostere.J. Med. Chem. 36:288–291 (1993).

    Article  CAS  PubMed  Google Scholar 

  7. V. Herbert, K. Lau, C. W. Gottlieb, and S. J. Bleicher. Coated charcoal immunoassay of insulin.J. Clin. Endocrinol. Metab. 25:1375–1384 (1965).

    Article  CAS  PubMed  Google Scholar 

  8. C. M. Metzler, G. K. Elfring and A. J. McEwen. A package of computer programs for pharmacokinetic modeling.Biometrics 30:562–563 (1974).

    Article  Google Scholar 

  9. W. J. Jusko and M. Gretch. Plasma and tissue protein binding of drugs in pharmacokinetics.Drug Met. Rev. 5:43–140 (1976).

    Article  CAS  Google Scholar 

  10. M. C. Meyer and D. E. Gutman. Dynamic dialysis as a method for studying protein binding II: Evaluation of the method with a number of binding systems.J. Pharm. Sci. 59:39–48 (1970).

    Article  CAS  PubMed  Google Scholar 

  11. M. C. Meyer and D. E. Gutman. Novel method for studying protein binding.J. Pharm. Sci. 57:1627–1629 (1968).

    Article  CAS  PubMed  Google Scholar 

  12. J. S. Robertson and B. W. Madsen. Kinetic approach to drug-protein binding.J. Pharm. Sci. 63:234–239 (1974).

    Article  CAS  PubMed  Google Scholar 

  13. J. Jacobesen and O. Fedders. Determination of non-albumin-bound bilirubin in human serum.J. Clin. Lab. Invest. 26:237–241 (1970).

    Article  Google Scholar 

  14. A. Sevenson, E. Holmer, and L. Andersson. A new method for the measurement of dissociation rates for complexes between small ligands and proteins as applied to the palmitate and bilirubin complexes with serum albumin.Biochim. Byophys. Acta 342:54–59 (1974).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yuan, J., Yang, D.C., Birkmeier, J. et al. Determination of protein binding byin vitro charcoal adsorption. Journal of Pharmacokinetics and Biopharmaceutics 23, 41–55 (1995). https://doi.org/10.1007/BF02353785

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02353785

Key words

Navigation